Open Save New
FeedNavigator / National Library of Health Sciences
Tutkijat / Kuopio
AddAiraksinen, O(lavi)
AddAlhava, E.
AddAlhonen, L.
AddAtalay, M(ustafa)
AddCederberg, H.
AddDunkel, L(eo)
AddEskelinen, M(atti)
AddGiniatullin, R.
AddGröhn, O(lli)
AddHarno, K.
AddHartikainen, J(aana).
AddHartikainen, J(uha).
AddHarvima, I.
AddHiltunen, M(ikko)
AddJääskeläinen, J(uha) E.
AddJäkälä, P(ekka)
AddJänne, J.
AddJantunen, E(sa)
AddJärvinen, R.
AddJulkunen, P.
AddKaikkonen, M(inna) U.
AddKauhanen, J(ussi)
AddKivipelto, M(iia)
AddKoistinaho, M.
AddKoivisto, T(imo)
AddKokki, H.
AddKönönen, M.
AddKosma, V(eli)-M(atti)
AddKröger, H.
AddKurl, S(udhir)
AddKuusisto, J(ohanna)
AddLaakso, M(arkku)
AddLakka, T(imo) A.
AddLapinlampi, N(iina)
AddLaukkanen, J(ari) (UEF/KSSHP)
AddLevonen, A(nna)-L(iisa)
AddLindgren, A(ntti) E.
AddLöppönen, H(eikki)
AddMannermaa, A.
AddManninen, H.
AddMecklin, J(ukka)-P(ekka)
AddMoilanen, L(eena)
AddMönkkönen, J.
AddMykkänen, H.
AddNuutinen, J.
AddPaajanen, H.
AddPaananen, J.
AddPalvimo, J.J.
AddPelkonen, J(ukka)
AddPihlajamäki, J(ussi)
AddPihlajamäki, M.
AddPitkänen, A(sla)
AddPunnonen, K.
AddRaatikainen K
AddRauramaa, R.
AddRissanen, T.T.
AddRoine, R(isto) P.
AddRyynänen, O.P.
AddSaarikoski, S.
AddSchwab, U(rsula)
AddSivenius, J.
AddSoininen, H(ilkka)
AddSoininen, P(asi)
AddSorri, I.
AddStancakova, A(lena)
AddSulkava, R.
AddSund, R(eijo)
AddTammi, M.
AddTanila, H(eikki)
AddTiihonen, J(ari)
AddUusaro, A.
AddUusitupa, M.
AddVanninen, R.
AddVaskilampi, T.
AddViinamäki, H(eimo)
AddVirtanen, M(arianna)
AddVoutilainen, R(aimo)
AddVoutilainen, S(ari)
AddWahlfors, J.
AddWirth, T.
AddWong, G.
AddYlä-Herttuala, S(eppo)

Scholar Chart >>

»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.Kosma, V(eli)-M(atti)182 dayssaveRefWorks
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.Kosma, V(eli)-M(atti)188 dayssaveRefWorks
Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.Kosma, V(eli)-M(atti)231 dayssaveRefWorks
High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.Kosma, V(eli)-M(atti)264 dayssaveRefWorks
Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.Kosma, V(eli)-M(atti)385 dayssaveRefWorks
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.Kosma, V(eli)-M(atti)387 dayssaveRefWorks
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.Kosma, V(eli)-M(atti)392 dayssaveRefWorks
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools.Kosma, V(eli)-M(atti)397 dayssaveRefWorks
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.Kosma, V(eli)-M(atti)566 dayssaveRefWorks
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.Kosma, V(eli)-M(atti)773 dayssaveRefWorks
Genome-wide association study of germline variants and breast cancer-specific mortality.Kosma, V(eli)-M(atti)886 dayssaveRefWorks
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.Kosma, V(eli)-M(atti)953 dayssaveRefWorks
Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.Kosma, V(eli)-M(atti)1057 dayssaveRefWorks
Tumor-infiltrating lymphocytes associate with outcome in non-endemic nasopharyngeal carcinoma: a multicenter study.Kosma, V(eli)-M(atti)1102 dayssaveRefWorks
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Kosma, V(eli)-M(atti)1134 dayssaveRefWorks
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.Kosma, V(eli)-M(atti)1253 dayssaveRefWorks
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.Kosma, V(eli)-M(atti)1295 dayssaveRefWorks
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.Kosma, V(eli)-M(atti)1314 dayssaveRefWorks
Body mass index and breast cancer survival: a Mendelian randomization analysis.Kosma, V(eli)-M(atti)1323 dayssaveRefWorks
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.Kosma, V(eli)-M(atti)1357 dayssaveRefWorks
Association analysis identifies 65 new breast cancer risk loci.Kosma, V(eli)-M(atti)1373 dayssaveRefWorks
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Kosma, V(eli)-M(atti)1373 dayssaveRefWorks
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.Kosma, V(eli)-M(atti)1475 dayssaveRefWorks
Combined Gene Therapy Using AdsVEGFR2 and AdsTie2 With Chemotherapy Reduces the Growth of Human Ovarian Cancer and Formation of Ascites in Mice.Kosma, V(eli)-M(atti)1537 dayssaveRefWorks
Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.Kosma, V(eli)-M(atti)1595 dayssaveRefWorks
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.Kosma, V(eli)-M(atti)1599 dayssaveRefWorks
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Kosma, V(eli)-M(atti)1629 dayssaveRefWorks
Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.Kosma, V(eli)-M(atti)1652 dayssaveRefWorks
Genome-wide association study identifies novel breast cancer susceptibility loci.Kosma, V(eli)-M(atti)1708 dayssaveRefWorks
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.Kosma, V(eli)-M(atti)1715 dayssaveRefWorks
Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.Kosma, V(eli)-M(atti)1727 dayssaveRefWorks
Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Kosma, V(eli)-M(atti)1755 dayssaveRefWorks
High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.Kosma, V(eli)-M(atti)1762 dayssaveRefWorks
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Kosma, V(eli)-M(atti)1772 dayssaveRefWorks
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Kosma, V(eli)-M(atti)1784 dayssaveRefWorks
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).Kosma, V(eli)-M(atti)1784 dayssaveRefWorks
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.Kosma, V(eli)-M(atti)1785 dayssaveRefWorks
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.Kosma, V(eli)-M(atti)1798 dayssaveRefWorks
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.Kosma, V(eli)-M(atti)1799 dayssaveRefWorks
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.Kosma, V(eli)-M(atti)1802 dayssaveRefWorks
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.Kosma, V(eli)-M(atti)1834 dayssaveRefWorks
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Kosma, V(eli)-M(atti)1841 dayssaveRefWorks
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers.Kosma, V(eli)-M(atti)1874 dayssaveRefWorks
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.Kosma, V(eli)-M(atti)1917 dayssaveRefWorks
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Kosma, V(eli)-M(atti)1926 dayssaveRefWorks
Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Kosma, V(eli)-M(atti)1928 dayssaveRefWorks
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.Kosma, V(eli)-M(atti)1937 dayssaveRefWorks
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Kosma, V(eli)-M(atti)1974 dayssaveRefWorks
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.Kosma, V(eli)-M(atti)1977 dayssaveRefWorks
Genetic predisposition to ductal carcinoma in situ of the breast.Kosma, V(eli)-M(atti)1987 dayssaveRefWorks
 XML / RSS feed
next »